The mean (95% CI) overall survival time was 32.2 (23.0 - 41.4) and 95.7 (83.7 - 107.8) months respectively for patients with and without CD133 expression in HCC (P = 0.001). This evidence concerns the gene PROM1 and hepatocellular carcinoma.